Q: What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.
 The Molecule can be represented with the SMILES CC(=O)[N-]S(=O)(=O)c1ccc(N)cc1.O.[Na+].
Result: Approved
{#Question|Q!}: {quest#}
{#Constraint:|Description:|!} The {#Molecule|Compound|Chemical!} {#has the|can be represented with the!} {SMILES__description} {SMILES#}.
{#Answer|Result|Answer!}: {answ#}
CC(=O)[N-]S(=O)(=O)c1ccc(N)cc1.O.[Na+]
CC(=O)[N-]S(=O)(=O)c1ccc(N)cc1.O.[Na+]
sodium;acetyl-(4-aminophenyl)sulfonylazanide;hydrate
What is the highest development stage achieved for this compound across all indications? Please respond with Approved, Phase 3 Clinical Trials, Phase 2 Clinical Trials, Phase 1 Clinical Trials, Early Phase 1 Clinical Trials, or Clinical Phase Unknown.